about
Modification of blood vessel diameter following perivascular application of botulinum toxin-APotent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.Therapeutic use of botulinum toxin in migraine: mechanisms of action.Review of botulinum toxin type A and its clinical applications in migraine headache.Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BSubstrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxicationSynaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.Clinical uses of botulinum neurotoxins: current indications, limitations and future developmentsUse of botulinum toxins in cancer therapy.Apoptotic action of botulinum toxin on masseter muscle in rats: early and late changes in the expression of molecular markers.Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells.Ganglion impar block with botulinum toxin type a for chronic perineal pain -a case report-.Botulinum toxin type B (Myobloc, NeuroBloc): a new choice in cervical dystonia.Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles.Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment.
P2860
Q30434923-FC3DC32E-04D6-4836-9DB8-B76D61DD7B6AQ34038244-BD2692AD-986E-4807-85E6-05C6CDE2366CQ34419654-9B00EC6B-E88D-4DFD-9D40-34E6CB4D88FFQ34515421-3599DD7A-DA9F-45E5-8A49-FAFC9DB65E68Q35779652-6A7C851B-FBBF-46C2-A4B7-9CFA47498CD4Q36301587-4083F823-4DC2-4C05-A0EC-A1F4154CE857Q36325534-2D6C699A-04DF-4A9D-8B8B-3A6348D057D4Q36395728-48C66469-6326-4381-89A5-2E7FC0AE2173Q36715757-51E9D9AE-C808-4B2D-A1C5-D4333CFEE540Q37075393-853EFCDF-4D30-4F16-88DF-5D4D99B6467FQ37570865-390E4E52-CB8F-40A4-A7B8-CB770C7EB276Q38484402-C5A795DA-2373-432C-8105-9DA0868096A6Q46049929-D484CD34-D02B-4A3F-BA91-2C2245B0710EQ46575974-86E6DAB3-FE64-407C-B3A6-EA9BB53B8731Q48044724-D1F084E2-3FB4-4FE5-BB28-50309F9C4052Q52923735-51D04DF6-5676-46F6-A09A-4EA7CD62D0EF
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The current use of botulinum toxin.
@ast
The current use of botulinum toxin.
@en
The current use of botulinum toxin.
@nl
type
label
The current use of botulinum toxin.
@ast
The current use of botulinum toxin.
@en
The current use of botulinum toxin.
@nl
prefLabel
The current use of botulinum toxin.
@ast
The current use of botulinum toxin.
@en
The current use of botulinum toxin.
@nl
P2093
P356
P1476
The current use of botulinum toxin.
@en
P2093
P304
P356
10.1054/JOCN.2000.0684
P577
2000-09-01T00:00:00Z